Skip to main content

Advertisement

Log in

Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Background

Non-functioning pituitary macroadenomas (NFPAs) with visual field defects are ideally managed by transsphenoidal tumour resection to improve vision, and long-term postsurgical follow up is necessary to monitor for tumour recurrence. Regular updates from global data are necessary for developing optimal management strategies of these tumours.

Methods

Pre- and postoperative visual and endocrine profile, imaging characteristics and details of surgical interventions among patients with NFPAs managed between 2008 and 2019 in a UK regional centre were assessed. The radiological and surgical outcomes including postoperative complications, recurrence risk and the factors influencing outcomes also were assessed.

Results

105 cases with mean (SD) age 60.1 (14.3) years and follow-up duration 60 (37) months were studied. 67 (64%) patients were male. Five-year recurrence-free survival rate was 71.5% (95% confidence interval [CI] 62.7% to 81.6%) with 33 (31%) tumour recurrences of whom 20 (60%) received radiotherapy and 9 (27%) underwent further surgery. Younger age, tumour volume, and bilateral cavernous sinus extension were the predictors of recurrence on univariate analysis, while younger age was the only factor on multivariate analysis (Hazard ratio 0.95; 95% CI: 0.92, 0.97). 72/78 patients (92%) with preoperative visual field defects improved after surgery, of whom 27 (35%) had full recovery. 20 (24%) patients had recovery of an abnormal hormone axis. 15 patients (16%) developed perioperative complications such as cerebrospinal fluid leak (12 cases), meningitis (2 cases), and bleeding (2 cases).

Conclusions

Five-year recurrence-free survival after transsphenoidal resection for NFPAs was 71.5% with older age at surgery conferring lower risk of recurrence. Visual recovery/ improvement occurred in 92% of cases with preoperative visual defects following surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. H. Gittleman, Q.T. Ostrom, P.D. Farah, A. Ondracek, Y. Chen, Y. Wolinsky, C. Kruchko, J. Singer, V.R. Kshettry, E.R. Laws, A.E. Sloan, W.R. Selman, J.S. Barnholtz-Sloan, Descriptive epidemiology of pituitary tumors in the United States, 2004–2009. J. Neurosurg. 121, 527–535 (2014). https://doi.org/10.3171/2014.5.JNS131819

    Article  PubMed  Google Scholar 

  2. S. Ezzat, S.L. Asa, W.T. Couldwell, C.E. Barr, W.E. Dodge, M.L. Vance, I.E. McCutcheon, The prevalence of pituitary adenomas. Cancer 101(3), 613–619 (2004). https://doi.org/10.1002/cncr.20412

    Article  PubMed  Google Scholar 

  3. T.T. Agustsson, T. Baldvinsdottir, J.G. Jonasson, E. Olafsdottir, V. Steinthorsdottir, G. Sigurdsson, A.V. Thorsson, P.V. Carroll, M. Korbonits, R. Benediktsson, The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study. Eur. J. Endocrinol. 173(5), 655–664 (2015). https://doi.org/10.1530/EJE-15-0189

    Article  CAS  PubMed  Google Scholar 

  4. S. Melmed, Pituitary-tumor endocrinopathies. N. Engl. J. Med. 382(10), 937–950 (2020). https://doi.org/10.1056/NEJMra1810772

    Article  CAS  PubMed  Google Scholar 

  5. B.D. McDowell, R.B. Wallace, R.M. Carnahan, E.A. Chrischilles, C.F. Lynch, J.A. Schlechte, Demographic differences in incidence for pituitary adenoma. Pituitary 14(1), 23–30 (2011). https://doi.org/10.1007/s11102-010-0253-4

    Article  PubMed  PubMed Central  Google Scholar 

  6. J.W. Lucas, M.E. Bodach, L.M. Tumialan, N.M. Oyesiku, C.G. Patil, Z. Litvack, M.K. Aghi, G. Zada, Congress of neurological surgeons systematic review and evidence-based guideline on primary management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79(4), E533–E535 (2016). https://doi.org/10.1227/NEU.0000000000001389

    Article  PubMed  Google Scholar 

  7. O.M. Dekkers, A.M. Pereira, J.A. Romijn, Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J. Clin. Endocrinol. Metab. 93(10), 3717–3726 (2008). https://doi.org/10.1210/jc.2008-0643

    Article  CAS  PubMed  Google Scholar 

  8. P. Mortini, M. Losa, R. Barzaghi, N. Boari, M. Giovanelli, Results of trans-sphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56(6), 1222–1233 (2005). https://doi.org/10.1227/01.neu.0000159647.64275.9d

    Article  PubMed  Google Scholar 

  9. P. Chanson, G. Raverot, F. Castinetti, C. Cortet-Rudelli, F. Galland, S. Salenave, French Endocrinology Society non-functioning pituitary adenoma work-group. Management of clinically non-functioning pituitary adenoma. Ann. Endocrinol. (Paris). 76(3), 239–247 (2015). https://doi.org/10.1016/j.ando.2015.04.002

    Article  PubMed  Google Scholar 

  10. M.E. Molitch, Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5), 516–524 (2017). https://doi.org/10.1001/jama.2016.19699

    Article  PubMed  Google Scholar 

  11. A.S. Little, P.A. Gardner, J.C. Fernandez-Miranda, M.R. Chicoine, G. Barkhoudarian, D.M. Prevedello, K.C.J. Yuen, D.F. Kelly, TRANSSPHER study group. pituitary gland recovery following fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenoma: results of a prospective multicenter study. J. Neurosurg. 15, 1–7 (2019). https://doi.org/10.3171/2019.8.JNS191012. NovOnline ahead of print

    Article  Google Scholar 

  12. M. Harary, A.C. DiRisio, H.Y. Dawood, J. Kim, N. Lamba, C.H. Cho, T.R. Smith, H.A. Zaidi, E.R. Laws, Endocrine function and gland volume after endoscopic transsphenoidal surgery for nonfunctional pituitary macroadenomas. J. Neurosurg. 1, 1–10 (2018). https://doi.org/10.3171/2018.5.JNS181054. NovOnline ahead of print

    Article  Google Scholar 

  13. A. Najmaldin, M. Malek, N.H. Madani, M. Ghorbani, H. Akbari, A. Khajavi, O.A. Qadikolaei, M.E. Khamseh, Non-functioning pituitary macroadenoma: surgical outcomes, tumor regrowth, and alterations in pituitary function-3-year experience from the iranian pituitary tumor registry. Hormones (Athens). 18(2), 197–205 (2019). https://doi.org/10.1007/s42000-019-00109-5

    Article  PubMed  Google Scholar 

  14. J.H. Kim, Y.S. Dho, Y.H. Kim, J.H. Lee, J.H. Lee, A.R. Hong, C.S. Shin, Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas. J. Neurosurg. 131(2), 500–506 (2018). https://doi.org/10.3171/2018.4.JNS172148

    Article  PubMed  Google Scholar 

  15. M.J. Levy, I.J. Robertson, N. Khalk, S. Vitello, N. Reddy, R. Bhake, T.A. Howlett, Long-term follow-up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: the outcome of a conservative management policy. Clin. Endocrinol. (Oxf.). 89(3), 354–359 (2018). https://doi.org/10.1111/cen.13791

    Article  PubMed  Google Scholar 

  16. N.J. Gittoes, A.S. Bates, W. Tse, B. Bullivant, M.C. Sheppard, R.N. Clayton, P.M. Stewart, Radiotherapy for non-function pituitary tumours. Clin. Endocrinol. (Oxf.). 48(3), 331–337 (1998). https://doi.org/10.1046/j.1365-2265.1998.00393.x

    Article  CAS  PubMed  Google Scholar 

  17. Y. Chen, C.D. Wang, Z.P. Su, Y.X. Chen, L. Cai, Q.C. Zhuge, Z.B. Wu, Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Neuroendocrinology 96(4), 333–342 (2012). https://doi.org/10.1159/000339823

    Article  CAS  PubMed  Google Scholar 

  18. E.P. O’Sullivan, C. Woods, N. Glynn, L.A. Behan, R. Crowley, P. O’Kelly, D. Smith, C.J. Thompson, A. Agha, The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin. Endocrinol. (Oxf.). 71(5), 709–714 (2009). https://doi.org/10.1111/j.1365-2265.2009.03583.x

    Article  PubMed  Google Scholar 

  19. J.P. Almeida, R. Tabasinejad, A. Kalyvas, H. Takami, N. Mohan, P.J. O’Halloran, M.M. Sanchez, C. Velasquez, G. Zadeh, F. Gentili, The importance of long term follow up after endoscopic pituitary surgery: durability of results and tumor recurrence. Neurol. India 68, S92–S100 (2020). https://doi.org/10.4103/0028-3886.287675

    Article  PubMed  Google Scholar 

  20. A.F. Haddad, J.S. Young, T. OH, M.P. Pereira, R.S. Joshi, K.M. Pereira, R.C. Osorio, K.C. Donohue, Z. Peeran, S. Sudhir, S. Jain, A. Beniwal, A.S. Chopra, N.S. Sandhu, P.V. Theodosopoulos, S. Kunwar, I.H. El-Sayed, J. Gurrola, L.S. Blevins, M.K. Aghi, Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution. Neurosurg. Focus. 48(6), E13 (2020). https://doi.org/10.3171/2020.3.FOCUS20114

    Article  PubMed  Google Scholar 

  21. M.M. Gerges, K. Rumalla, S.S. Godil, I. Younus, W. Elshamy, G.A. Dobri, A. Kacker, A. Tabaee, V.K. Anand, T.H. Schwartz, Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas. J. Neurosurg. 2020;1–12. https://doi.org/10.3171/2019.11.JNS192457

  22. A.L. Pappy II., A. Savinkina, C. Bicknese, S. Neill, N.M. Oyesiku, A.G. Ioachimescu, Predictive modeling for pituitary adenomas: single center experience in 501 consecutive patients. Pituitary 22(5), 520–531 (2019). https://doi.org/10.1007/s11102-019-00982-8

    Article  PubMed  Google Scholar 

  23. R.L. Batista, E.B. Trarbach, M.D. Marques, V.A. Cescato, G.O. da Silva, C.G.B. Herkenhoff, M.B. Cunha-Neto, N.R. Musolino, Nonfunctioning pituitary adenoma recurrence and its relationship with sex, size, and hormonal immunohistochemical profile. World Neurosurg. 120, e241–e246 (2018). https://doi.org/10.1016/j.wneu.2018.08.043

    Article  PubMed  Google Scholar 

  24. R. Reddy, S. Cudlip, J.V. Byrne, N. Karavitaki, J.A. Wass, Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma? Eur. J. Endocrinol. 165(5), 739–744 (2011). https://doi.org/10.1530/EJE-11-0566

    Article  CAS  PubMed  Google Scholar 

  25. J. Lelotte, A. Mourin, E. Fomekong, A. Michotte, C. Raftopoulos, D. Maiter, Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients. Eur. J. Endocrinol. 178(3), 237–246 (2018). https://doi.org/10.1530/EJE-17-0965

    Article  CAS  PubMed  Google Scholar 

  26. A.K. Watts, A. Easwaran, P. McNeill, Y.Y. Wang, W.J. Inder, C. Caputo, Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: Results from a single Australian centre. Clin. Endocrinol. (Oxf.). 87(3), 264–271 (2017). https://doi.org/10.1111/cen.13365

    Article  PubMed  Google Scholar 

  27. F. Langlois, D.S.T. Lim, E. Varlamov, C.G. Yedinak, J.S. Cetas, S. McCartney, A. Dogan A, M. Fleseriu, Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58(3), 528–534 (2017). https://doi.org/10.1007/s12020-017-1447-6

    Article  CAS  PubMed  Google Scholar 

  28. T. Ogiwara, A. Nagm, T. Nakamura, T. Mbadugha, T. Horiuchi, K. Hongo, Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas. World Neurosurg. 128, e752–e759 (2019). https://doi.org/10.1016/j.wneu.2019.04.250

    Article  PubMed  Google Scholar 

  29. I.C.M. Pelsma, M.J.T. Verstegen, F. de Vries, I.C. Notting, M.L.D. Broekman, W.R. van Furth, N.R. Biermasz, A.M. Pereira, Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study. Pituitary. 2020;23(4):417–429. https://doi.org/10.1007/s11102-020-01061-z

  30. M. Araujo-Castro, E. Pascual-Corrales, A. Acitores Cancela, S. García Duque, L. Ley Urzaiz, V.Rodríguez Berrocal, Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients. Endocrine 70(3), 584–592 (2020). https://doi.org/10.1007/s12020-020-02455-6

    Article  CAS  PubMed  Google Scholar 

  31. A. Jahangiri, J.R. Wagner, S.W. Han, M.T. Tran, L.M. Miller, R. Chen, M.W. Tom, L.R. Ostling, S. Kunwar, L. Blevins, M.K. Aghi, Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis. J. Neurosurg. 124(3), 589–595 (2016). https://doi.org/10.3171/2015.1.JNS141543

    Article  CAS  PubMed  Google Scholar 

  32. N. Fatemi, J.R. Dusick, C. Mattozo, D.L. McArthur, P. Cohan, J. Boscardin, C. Wang, R.S. Swerdloff, D.F. Kelly, Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63(4), 709–718 (2008). https://doi.org/10.1227/01.NEU.0000325725.77132.90

    Article  PubMed  Google Scholar 

  33. E. Magro, T. Graillon, J. Lassave, F. Castinetti, S. Boissonneau, E. Tabouret, S. Fuentes, L. Velly, R. Gras, H. Dufour, Complications related to the endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary macroadenomas in 300 consecutive patients. World Neurosurg. 89, 442–453 (2016). https://doi.org/10.1016/j.wneu.2016.02.059

    Article  PubMed  Google Scholar 

  34. P. Riesgo, P. Mariño, A. Platero, F.J. Tarazona, C. Fajardo, J.L. Llácer, V. Rovira, R. Rodríguez, A. Flor-Goikoetxea, J. Piquer, Postoperative CSF leakages after transsphenoidal surgery for pituitary adenomas: analysis of a series of 302 surgical procedures. Fístulas posquirúrgicas de líquido cefalorraquídeo tras cirugía transesfenoidal de adenomas hipofisarios: análisis de una serie de 302 intervenciones. Neurocirugia (Astur.). 30(5), 215–221 (2019). https://doi.org/10.1016/j.neucir.2019.03.003

    Article  PubMed  Google Scholar 

  35. S.M. Graham, T.A. Iseli, L.H. Karnell, J.D. Clinger, P.W. Hitchon, J.D. Greenlee, Endoscopic approach for pituitary surgery improves rhinologic outcomes. Ann. Otol. Rhinol. Laryngol. 118(9), 630–635 (2009). https://doi.org/10.1177/000348940911800905

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joseph M. Pappachan.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Subramanian, V., Lee, R.S.M., Howell, S. et al. Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function. Endocrine 73, 407–415 (2021). https://doi.org/10.1007/s12020-021-02713-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02713-1

Keywords

Navigation